Trials / Sponsors / Ability Pharmaceuticals SL
Ability Pharmaceuticals SL
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | ABTL0812 in Combination With FOLFIRINOX for First-line Treatment of Metastatic Pancreatic Study Pancreatic Cancer | Phase 1 / Phase 2 | 2021-05-06 |
| Suspended | A Study of ABTL0812 in Pancreatic Cancer Pancreatic Cancer | Phase 1 / Phase 2 | 2021-04-26 |
| Completed | A Study to Assess the Efficacy and Safety of ABTL0812 Endometrial Cancer, Squamous Non-Small Cell Lung Cancer | Phase 1 / Phase 2 | 2016-12-01 |
| Completed | Phase I/Ib Clinical Trial of ABTL0812 in Advanced Cancer Patients Cancer | Phase 1 | 2014-02-01 |